Skip to content

Psyhosomatic Medicine in Oncologic and Cardiac Disease Study

Retrospective and Prospective Observational Study on Cardiological and Oncological Psychosomatics

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03437642
Acronym
PSYCHONIC
Enrollment
220
Registered
2018-02-19
Start date
2018-03-27
Completion date
2022-12-31
Last updated
2019-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction, Breast Cancer, Tako Tsubo Cardiomyopathy

Brief summary

Psychological processes play a complex role in the pathophysiology of many diseases. However, the body and emotional perception of patients and the relationship between dreams and disease still need to be investigated. The investigators planned an observational and controlled research aimed at assessing some previously unaddressed baseline psychological characteristics and their changes at 1 and 5 years after a short-term psychotherapy in carefully characterised patients with heart or oncologic diseases . The patients that will be enrolled are: * 50 patients ≤ 75 year old with acute myocardial infarction; * 30 patients ≤ 75 year old with Tako-Tsubo syndrome; * 50 women ≤ 75 year old, recently operated on breast cancer: * 90 control subjects of the same age and gender of the enrolled patients, without relevant pathologies during the last 10 years. Relevant pathologies are defined as those that required a hospitalisation or a long-lasting medical therapy. At the enrolment all the subjects will undergo a complete medical evaluation, and the following psychometric tests: Self-evaluation test, Social Support Questionnaire, Beck Depression Inventory II (BDI II), MacNew Heart Disease Health-Related Quality of Life Questionnaire, State-Trait Anxiety Inventory (STAI), State-Trait Anger Expression Inventory (STAXI 2). In two distinct following meetings, an open questionnaire exploring the body and emotional perception, and another exploring past and recent dreams, will be administered. The same evaluation will be done for the healthy subjects. After the initial evaluation, all the patients will be given the choice to start a short-term psychotherapy lasting 6 months on top of medical therapy or to continue classic medical therapy only. Healthy subjects will be not offered the possibility to follow psychotherapy. At first year of follow-up, the battery of psychometric test, and the two questionnaires exploring the body and emotional perception, and changes and characteristics of dreams during the psychotherapy, will be re-administered. The following data will be evaluated: Psychological characteristics at follow-up. Incidence of new relevant medical events Quality of life Relationship between psychological characteristics and health status, and quality of life At 5 year follow-up psychometric tests and the clinical data will be evaluated in all the groups.

Interventions

BEHAVIORALShort Term Psychotherapy

Humanistic-existential psychotherapy derived from ontopsychological method and specifically adapted to public health systems. Individual and group sessions to be tailored to individual needs

Sponsors

San Filippo Neri General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients within one week from an Acute myocardial infarction treated with primary or urgent PCI * Patients within one week from the onset of Tako Tsubo cardiomyopathy. * Patients with a diagnosis of breast cancer in the preceding six months * Age and sex matched control subjects without relevant medical pathologies in the preceding 10 years

Exclusion criteria

* Cognitive impairment * Refusing the enrolment

Design outcomes

Primary

MeasureTime frameDescription
Cumulative incidence of new relevant medical eventsat 1 yearRelevant medical events are defined as any new medical condition significantly impairing normal daily activities or requiring hospitalization or needing specific and permanent drug treatment.

Secondary

MeasureTime frameDescription
Changes in body perception and dreamsat 1 yearThese changes will be evaluated with dedicated qualitative questionnaires formulated with open questions.
Incidence of rehospitalisationsat 1 yearNumber of rehospitalisations during the first year of follow-up
Distress gradeat 1 yearSelf-evaluation test (score range 1-10, higher stress for higher values)
Depression symptomsat 1 yearBeck depression inventory II (score range 0-63, more severe depression symptoms for higher values)
Cumulative incidence of new relevant medical eventsat 5 yearsRelevant medical events are defined as any new medical condition significantly impairing normal daily activities or requiring hospitalization or needing specific and permanent drug treatment.
Quality of lifeat 1 yearMac New Health-related quality of life questionnaire (score range 1-7, the higher the score the higher the quality of life, 4 subscales not merged)
Anxiety gradeAt 1 yearState-Trait Anxiety inventory (score range 20-80, the higher the score the more anxiety the patients has, 2 subscales)
Anger levelat 1 yearState-Trait Anger Expression inventory (score range 0%-100%, the higher the score the higher the anger, two subscales)
Social supportat 1 yearSocial support questionnaire (score range 12-72, the higher the score the lower the support)

Countries

Italy

Contacts

Primary ContactAdriana Roncella, MD
adrianaroncella@hotmail.it+39060633062504

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026